• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Lifirafenib Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5756800

Lifirafenib (BGB-283) is a potent inhibitor of RAF family kinases and EGFR in biochemical assays with IC50 of 23, 29 and 495nM for the recombinant BRAFV600E kinase domain, EGFR and EGFR T790M/L858R mutant respectively. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Lifirafenib, Inhibitor
Full Product Name
Lifirafenib
Product Synonym Names
Beigene-283; BGB-283
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
478.42
Solubility
<1mg/ml refers to the product slightly soluble or insoluble
Formula
C25H17F3N4O3
CAS Number
1446090-79-4
Target & IC50
BRAF WT: ic50 32nM
BRAF(V600E): ic50 23nM
C-RAF (Y340/341D): ic50 7nM
EGFR: ic50 29nM
WT A-RAF: ic50 1nM

Product References and Citations for Lifirafenib, inhibitor

Tang Z, et al. Mol Cancer Ther. 2015, 14(10):2187-97.

Other Notes

Small volumes of Lifirafenib, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Lifirafenib purchase

MBS5756800 is an inhibitor targeting Lifirafenib.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000